Biogen BIIB
NASDAQ BIIB
$215.45 +4.72 (+2.24%)
As of: Sep 10, 2026 · 3:59 PM EDT

Biogen (BIIB) Exchange Rate Effect (2009 - 2026)

Biogen (BIIB) posted Exchange Rate Effect of -$3.4 million for Q2 2026, up 81.11% on a QoQ basis from -$18.0 million in Q1 2026, and down 104.98% year-over-year from $68.3 million in Q2 2025.

Analysis

Biogen (BIIB) Exchange Rate Effect (2009 - 2026) Analysis & Trends

Biogen has reported Exchange Rate Effect for 18 years, with the latest figure at -$3.4 million in Q2 2026.

  • On a quarterly basis, Exchange Rate Effect fell 104.98% year-over-year to -$3.4 million in Q2 2026; TTM through Jun 2026 was -$22.1 million, a 131.3% decrease from a year earlier, with the FY2025 full-year figure at $101.9 million, up 250.52% from the prior year.
  • Exchange Rate Effect was -$3.4 million for Q2 2026 at Biogen, up from -$18.0 million in the prior quarter.
  • The five-year high for Exchange Rate Effect was $68.3 million in Q2 2025, with the low at -$74.4 million in Q4 2024.
  • Average Exchange Rate Effect over 5 years is -$433333.3, with a median of -$3.8 million recorded in 2023.
  • The sharpest annual moves came in 2022 and 2025: Exchange Rate Effect sank 525.0% in 2022, then jumped 642.06% in 2025.
  • Over 5 years, Exchange Rate Effect stood at $67.2 million in 2022, then declined by 28.72% to $47.9 million in 2023, then sank by 255.32% to -$74.4 million in 2024, then soared by 103.36% to $2.5 million in 2025, then tumbled by 236.0% to -$3.4 million in 2026.
  • The last three Exchange Rate Effect figures came in at -$3.4 million (Q2 2026), -$18.0 million (Q1 2026), and $2.5 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Exchange Rate Effect (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -19.00 Mn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -3.70 Mn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn -300,000.00
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -2.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -2.45 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -3.40 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 315,000.00
10 Insmed 27.67 Bn 26.51 Bn 358.27 Mn -287,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.40 Mn
Mar 31, 2026 -18.00 Mn
Dec 31, 2025 2.50 Mn
Sep 30, 2025 -3.20 Mn
Jun 30, 2025 68.30 Mn
Mar 31, 2025 34.30 Mn
Dec 31, 2024 -74.40 Mn
Sep 30, 2024 42.40 Mn
Jun 30, 2024 -12.60 Mn
Mar 31, 2024 -23.10 Mn
Dec 31, 2023 47.90 Mn
Sep 30, 2023 -28.70 Mn
Jun 30, 2023 -4.10 Mn
Mar 31, 2023 20.00 Mn
Dec 31, 2022 67.20 Mn
Sep 30, 2022 -52.30 Mn
Jun 30, 2022 -61.20 Mn
Mar 31, 2022 -9.40 Mn
Dec 31, 2021 -15.80 Mn
Sep 30, 2021 -25.40 Mn